58083-34-4

Usage

Uses

Used in Pharmaceutical Industry:
N-(PIPERIDIN-4-YL)ACETAMIDE HYDROCHLORIDE is used as a pharmaceutical intermediate for the synthesis of various drugs, leveraging its chemical properties to facilitate the development of new medicinal compounds.
Used in Neurological and Psychiatric Applications:
N-(PIPERIDIN-4-YL)ACETAMIDE HYDROCHLORIDE is used as a potential therapeutic agent for the treatment of neurological and psychiatric disorders, due to its studied effects on the central nervous system.
Used in Analgesic and Anti-inflammatory Applications:
N-(PIPERIDIN-4-YL)ACETAMIDE HYDROCHLORIDE is used as an analgesic and anti-inflammatory agent, given its potential to alleviate pain and reduce inflammation, which are common therapeutic goals in various medical conditions.

Upstream product

• 1093759-67-1 tert-butyl 4-acetamidopiperidine-1-carboxylate 
• 873088-90-5 1,1-dimethylethyl 4-[bis(phenylmethyl)amino]-1-piperidinecarboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 

Relevant academic research and scientific papers

2-SUBSTITUTED-ETHYNYLTHIAZOLE DERIVATIVES AND USES OF SAME

The present invention provides 2-substituted-ethynylthiazole derivatives of formula (I): wherein R1, R2 and X are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods of using same.

Heterocyclic compouds

A compound of the general formula wherein: n is 0 or 1; M1 is an amino group; Q is an aromatic heterocyclic group containing a basic nitrogen atom; M2 is an imino group; L is a template group; and A is an acidic group, or an ester or amide derivative thereof, or a sulphonamide group; and pharmaceutically acceptable salts and pro-drugs thereof, for use in the treatment of a disease in which platelet aggregation mediated by the binding of adhesion molecules to GPIIb-IIIa is involved. Novel compounds are also disclosed.

Heterocyclic derivatives

Compounds of formula I STR1 and metabolically labile esters and amides thereof, and pharmaceutically acceptable salts thereof, in which R13, M2, X1, Z1, Z1a, X2 and A1 have the meanings given in the specification. The compounds are useful as inhibitors of the binding of fibrinogen to glycoprotein IIb/IIIa. Novel intermediates are also disclosed.

Heterocyclic derivatives

Compounds of formula I STR1 and metabolically labile esters and amides thereof, and pharmaceutically acceptable salts thereof, in which R13, M2, X1, Z1, Z1a, X2 and A1 have the meanings given in the specification. The compounds are useful as inhibitors of the binding of fibrinogen to glycoprotein IIb/IIIa. Intermediates are also disclosed.

Anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory 1-[(benzoylphenyl)-lower-alkyl]piperidines and analogs thereof

1-[(3- or 4-Benzoylphenyl)-lower-alkyl]-[(CH2)n --N=B]-substituted-piperidines, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents, are prepared by alkylation of an appropriate subs

Benzoylphenyl lower alkanoyl piperidines

1-[(3- or 4-Benzoylphenyl)-lower-alkyl]-[(CH2)n -N=B]-substituted-piperidines, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents, are prepared by alkylation of an appropriate subst